Aigul Galembikova

Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance

Sergei Boichuk, Aigul Galembikova, Ramil Khusnutdinov et al. · Oncology Letters · 2017 · 50 citations · Full text

Medicine, Oncology, Pharmacology +14

A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance

Sergei Boichuk, Aigul Galembikova, Pavel Dunaev et al. · Molecules · 2017 · 49 citations · Full text

Medicine, Genetics, Oncology +17

Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells

Sergei Boichuk, Pavel Dunaev, Shinjit Mani et al. · Biomedicines · 2022 · 36 citations · Full text

Medicine, Oncology, Pharmacology +12

The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site

Sergei Boichuk, Aigul Galembikova, Kirill Syuzov et al. · Molecules · 2021 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair

Sergei Boichuk, Firuza Bikinieva, Nurgatina Ilmira et al. · International Journal of Molecular Sciences · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17